[225Ac]Ac-PSMA-R2
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for [225Ac]Ac-PSMA-R2, covering 2025-12-22 to 2025-12-29. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess [177Lu]Lu-PSMA-R2 (AAA602) and [225Ac]Ac-PSMA-R2 (AAA802) in Participants With PSMA-positive HRLPC [Phase 1, Phase 2]